These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 6113997)
21. Beta-adrenergic receptor blocking drugs in spontaneous hypertension. Levy JV Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729 [TBL] [Abstract][Full Text] [Related]
22. Analysis of Clinical Efficacy and Adverse Effects of β-Blocking Agents Used Clinically for Chronic Heart Failure. Takayanagi R; Fujito K; Kimura K; Yamada Y Biol Pharm Bull; 2017; 40(6):837-843. PubMed ID: 28566627 [TBL] [Abstract][Full Text] [Related]
23. [Therapy of chronic heart failure--carvedilol vs. metoprolol. COMET Study]. Ertl G; Nitschmann S Internist (Berl); 2004 Jul; 45(7):835-6. PubMed ID: 15054581 [No Abstract] [Full Text] [Related]
24. COMET: a proposed mechanism of action to explain the results and concerns about dose. Coca SG; Buller GK Lancet; 2003 Sep; 362(9389):1076; author reply 1077-8. PubMed ID: 14522541 [No Abstract] [Full Text] [Related]
25. Comparison of safety and efficacy of carvedilol and metoprolol in stable angina pectoris. van der Does R; Hauf-Zachariou U; Pfarr E; Holtbrügge W; König S; Griffiths M; Lahiri A Am J Cardiol; 1999 Mar; 83(5):643-9. PubMed ID: 10080412 [TBL] [Abstract][Full Text] [Related]
26. [Is "COMET" pointing in the right direction?--Con]. Schneider CA Dtsch Med Wochenschr; 2003 Dec; 128(50):2667. PubMed ID: 14673748 [No Abstract] [Full Text] [Related]
27. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort. Tang CH; Wang CC; Chen TH; Hong CY; Sue YM J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790 [TBL] [Abstract][Full Text] [Related]
28. Beta-adrenergic receptor blocking drugs: tear lysozyme and immunological screening for adverse reaction. Mackie IA; Seal DV; Pescod JM Br J Ophthalmol; 1977 May; 61(5):354-9. PubMed ID: 17431 [TBL] [Abstract][Full Text] [Related]
29. Metoprolol and alopecia. Graeber CW; Lapkin RA Cutis; 1981 Dec; 28(6):633-4. PubMed ID: 7318502 [TBL] [Abstract][Full Text] [Related]
30. Dermatitis as a side-effect of long-term topical treatment with certain beta-blocking agents. van Joost T; Middelkamp J; Ros FE Br J Dermatol; 1979 Aug; 101(2):171-7. PubMed ID: 39586 [TBL] [Abstract][Full Text] [Related]
31. [Beta blockers for therapy of chronic heart failure]. Murakami T Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588 [No Abstract] [Full Text] [Related]
32. [Effect of celiprolol and metoprolol on serum lipids in patients with various forms of hyperlipoproteinemia]. Pristautz H; Stradner F Wien Med Wochenschr; 1986 Sep; 136(17):443-8. PubMed ID: 2879389 [TBL] [Abstract][Full Text] [Related]
33. Perioperative metoprolol and risk of stroke after noncardiac surgery. Mashour GA; Sharifpour M; Freundlich RE; Tremper KK; Shanks A; Nallamothu BK; Vlisides PE; Weightman A; Matlen L; Merte J; Kheterpal S Anesthesiology; 2013 Dec; 119(6):1340-6. PubMed ID: 23612244 [TBL] [Abstract][Full Text] [Related]
34. Side effects and contraindications of beta-receptor blocking agents. Lydtin H Klin Wochenschr; 1977 May; 55(9):415-22. PubMed ID: 17766 [TBL] [Abstract][Full Text] [Related]
35. Dermatitis as side-effect of long-term metoprolol. Neumann HA; Van Joost T; Westerhof W Lancet; 1979 Oct; 2(8145):745. PubMed ID: 90833 [No Abstract] [Full Text] [Related]